Klaus Elenius
Åbo Akademi University(FI)University of Helsinki(FI)University of Turku(FI)Turku Centre for Computer Science(FI)Turku University Hospital(FI)Varsinais-Suomen Sairaanhoitopiiri(FI)Institute for Molecular Medicine Finland(FI)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, Proteoglycans and glycosaminoglycans research, Cell Adhesion Molecules Research
Most-Cited Works
- → Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab(2005)660 cited
- → Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation(1997)348 cited
- → High frequency of BRAFV600E mutations in ameloblastoma(2013)299 cited
- → Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer(2004)268 cited
- → Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells(2006)264 cited
- → Induced expression of syndecan in healing wounds.(1991)241 cited